HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients

BMC Public Health

Gonzalo Pérez¹  Juan Carlos Vargas³  Liliana Orjuela²  Gustavo Hernández-Suárez²  Marion Piñeros² 

[1] Merck Sharp & Dohme, Whitehouse Station, New Jersey, USA;Fundación para la Investigación y el Desarrollo, Bogotá, DC, Colombia;Profamilia, Bogotá, DC, Colombia

关键词: Colombia;    Patients;    Psychosexual impact;    HPV;    Genital warts;   

Others  :  1162408
DOI  :  10.1186/1471-2458-13-272

 received in 2012-10-31, accepted in 2013-03-14,  发布年份 2013

【 摘 要 】

Background

Information on HPV knowledge in patients with genital warts is scarse as is the information on factors related to the impact on self-esteem and sex life among them.

Methods

We conducted a cross-sectional study in adult patients with a clinical diagnosis of genital warts (GW) attending a major private out-patient clinic in Bogotá, Colombia. Patients underwent biopsy for pathological diagnosis, HPV-DNA testing and completed a questionnaire assessing HPV knowledge, and the consequences of GW on self-esteem and sexual life. Differences in proportions were assessed with a chi² test.

Results

106 men and 155 women had pathologic confirmation of GW. 51% of subjects had heard of HPV before consultation coming mainly from the media (82%). Less than half of the participants knew that HPV could be transmitted through non-penetrant sexual intercourse and only two thirds acknowledged HPV vaccine as a preventive measure against HPV infection. Impact on self-esteem was higher among women than men (90.3% vs 60.4%, [p < 0.01]). In men, factors related to a higher impact on sexual life were HPV awareness and age; in women they were higher education and anatomic location; external GW had a higher impact on sexual life in women (83% vs. 66%; [p = 0.05]).

Conclusions

We found a low awareness of HPV and low knowledge on the vaccine as a preventive measure for associated diseases even in patients suffering from genital warts, highlighting the need for communication and education on HPV. Greater impact on self-esteem in women might reflect higher health consciousness among Latin American women.

【 授权许可】

   
2013 Piñeros et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G: A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Canc Prev Res (Phila) 2009, 2(10):868-878.
• [2]Maw RD, Reitano M, Roy M: An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998, 9(10):571-578.
• [3]Insinga RP, Dasbach EJ, Elbasha EH: Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009, 9:119. BioMed Central Full Text
• [4]Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102(5A):3-8.
• [5]Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH: Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999, 37(10):3316-3322.
• [6]Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H: Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2010, S1473–3099(10):70225-5.
• [7]Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin D: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer: Lyon, France; 2010. http://globocan.iarc.fr webcite
• [8]Klug SJ, Hukelmann M, Blettner M: Knowledge about infection with human papillomavirus: a systematic review. Prev Med 2008, 46(2):87-98.
• [9]Hanisch R, Gustat J, Hagensee ME, Baena A, Salazar JE, Castro MV: Knowledge of Pap screening and human papillomavirus among women attending clinics in Medellin, Colombia. Int J Gynecol Canc 2008, 18(5):1020-1026.
• [10]Wiesner C, Pineros M, Trujillo LM, Cortes C, Ardila J: [Human papillomavirus (HPV) vaccine acceptability amongst parents of adolescents in four Colombian areas]. Rev Salud Publica (Bogota) 2010, 12(6):961-973.
• [11]Kuznetsov AV, Muller RA, Ruzicka T, Herzinger T, Kuznetsov L: Knowledge of sexually transmitted HPV infection, genitoanal warts, cancer and their prevention among young females after vaccine introduction in Germany. J Eur Acad Dermatol Venereol 2012.
• [12]Marlow LA, Zimet GD, McCaffery KJ, Ostini R, Waller J: Knowledge of human papillomavirus (HPV) and HPV vaccination: An international comparison. Vaccine 2013, 31:763-769.
• [13]Encuesta Nacional de Demografia y Salud, ENDS. Bogotá, Colombia: Profamilia; 2011.
• [14]Moreira ED Jr, de Oliveira BG, Neves RC, Costa S, Karic G, Filho JO: Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials. J Pediatr Adolesc Gynecol 2006, 19(2):81-87.
• [15]Woodhall SC, Jit M, Soldan K, Kinghorn G, Gilson R, Nathan M: The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex Transm Infect 2011, 87(6):458-463.
• [16]Waller J, Marlow LA, Wardle J: The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex Transm Infect 2007, 83(2):155-159.
• [17]Jeynes C, Chung MC, Challenor R: 'Shame on you'--the psychosocial impact of genital warts. Int J STD AIDS 2009, 20(8):557-560.
• [18]Ireland JA, Reid M, Powell R, Petrie KJ: The role of illness perceptions: psychological distress and treatment-seeking delay in patients with genital warts. Int J STD AIDS 2005, 16(10):667-670.
• [19]Clarke P, Ebel C, Catotti DN, Stewart S: The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996, 7(3):197-200.
• [20]Mortensen GL, Larsen HK: The quality of life of patients with genital warts: a qualitative study. BMC Publ Health 2010, 10:113. BioMed Central Full Text
• [21]Drewry J, Garces-Palacio IC, Scarinci I: Awareness and knowledge about human papillomavirus among Latina immigrants. Ethn Dis 2010, 20(4):327-333.
• [22]Kobetz E, Kornfeld J, Vanderpool RC, Finney Rutten LJ, Parekh N, O'Bryan G: Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun 2010, 15(Suppl 3):22-29.
• [23]Pitts MK, Heywood W, Ryall R, Smith AM, Shelley JM, Richters J: Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women. Sex Health 2010, 7(3):299-303.
• [24]Colon-Lopez V, Ortiz AP, Palefsky J: Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J 2010, 29(3):232-240.
• [25]Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S: Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination. BMC Publ Health 2008, 8:368. BioMed Central Full Text
• [26]Tiro JA, Meissner HI, Kobrin S, Chollette V: What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev 2007, 16:288-294.
• [27]Benning BR, Lund MR: Patient knowledge about human papillomavirus and relationship to history of abnormal Papanicolaou test results. J Low Genit Tract Dis 2007, 11(1):29-34.
• [28]Sach TH, Whynes DK: Men and women: beliefs about cancer and about screening. BMC Publ Health 2009, 9:431. BioMed Central Full Text
• [29]Persson G, Dahlof LG, Krantz I: Physical and psychological effects of anogenital warts on female patients. Sex Transm Dis 1993, 20(1):10-13.
• [30]Dediol I, Buljan M, Vurnek AIM, Bulat V, A Itum M, A Ubrilovia A: Psychological burden of anogenital warts. J Eur Acad Dermatol Venereol 2009, 23(9):1035-1038.
• [31]Ikkos G, Fitzpatrick R, Frost D, Nazeer S: Psychological disturbance and illness behaviour in a clinic for sexually transmitted diseases. Br J Med Psychol 1987, 60(Pt 2):121-126.
• [32]Drolet M, Brisson M, Maunsell E, Franco EL, Coutlee F, Ferenczy A: The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sex Transm Dis 2011, 38(10):949-956.
• [33]Mast TC, Zhu X, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG: Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin 2009, 25(11):2609-2619.
• [34]Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK: The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect 2009, 85(7):508-513.